3,983
Views
16
CrossRef citations to date
0
Altmetric
Clinical Research

A randomized trial comparing physostigmine vs lorazepam for treatment of antimuscarinic (anticholinergic) toxidrome

, , , , , & show all
Pages 698-704 | Received 12 Sep 2020, Accepted 17 Nov 2020, Published online: 09 Dec 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Matthew S. Correia & Robert G. Hendrickson. (2023) Improvement in delirium and visuospatial function after rivastigmine in antimuscarinic toxicity: a case report. Toxicology Communications 7:1.
Read now
Grant Comstock, Sasha Kaiser, Kennon Heard & George Sam Wang. (2022) Significance of temperature in antimuscarinic toxicity: a case-control study. Clinical Toxicology 60:9, pages 1070-1072.
Read now

Articles from other publishers (14)

James D. Whitledge, C. James Watson, Michael Simpson, Azza Bakkar, Leora Boussi, Michael Scott & Katherine L. Boyle. (2022) Diphenhydramine-Induced Antimuscarinic Delirium Treated with Physostigmine and Transdermal Rivastigmine. Journal of Medical Toxicology 19:2, pages 219-223.
Crossref
Tobias Hölle, Jan C. Purrucker, Benedict Morath, Markus A. Weigand & Felix C. F. Schmitt. (2023) Zentrales anticholinerges, malignes neuroleptisches und SerotoninsyndromCentral anticholinergic, neuroleptic malignant and serotonin syndromes. Die Anaesthesiologie.
Crossref
Jason Seebaluck, Michael A. Downes, Jared Brown, Keith Harris, Katherine Z. Isoardi & Betty S. Chan. (2022) Case series profile of olanzapine post‐injection delirium/sedation syndrome. British Journal of Clinical Pharmacology 89:2, pages 903-907.
Crossref
Beniamino Tripodi, Irene Matarese & Manuel Glauco Carbone. (2023) A Critical Review of the Psychomotor Agitation Treatment in Youth. Life 13:2, pages 293.
Crossref
James D. Whitledge, Erin R. Fox & Maryann Mazer-Amirshahi. (2022) Benzodiazepine Shortages: A Recurrent Challenge in Need of a Solution. Journal of Medical Toxicology 19:1, pages 4-6.
Crossref
Matthew T. Stanton. (2022) Part II : Interactive case: Toxicology and poison control . JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY 5:12, pages 1332-1337.
Crossref
N. Jeelan Basha, S. M. Basavarajaiah & K. Shyamsunder. (2022) Therapeutic potential of pyrrole and pyrrolidine analogs: an update. Molecular Diversity 26:5, pages 2915-2937.
Crossref
Michael E. Mullins. (2021) Physostigmine should be used more readily for antimuscarinic toxicity: CON. British Journal of Clinical Pharmacology 88:1, pages 61-63.
Crossref
Andrew Dawson. (2021) Physostigmine should be used more readily for antimuscarinic toxicity: PRO. British Journal of Clinical Pharmacology 88:1, pages 58-60.
Crossref
Christy Turco & Sidhartha D. Ray. 2022. Reference Module in Biomedical Sciences. Reference Module in Biomedical Sciences.
Mohamed Serhan Hamam & Andrew Bissonette. (2021) Evaluation and Management of Toxicological Causes of Delirium. Current Emergency and Hospital Medicine Reports 9:3, pages 55-63.
Crossref
Wilmarie Cidre Serrano & Jose Maldonado. (2021) The Use of Physostigmine in the Diagnosis and Treatment of Anticholinergic Toxicity After Olanzapine Overdose: Literature Review and Case Report. Journal of the Academy of Consultation-Liaison Psychiatry 62:3, pages 285-297.
Crossref
Lotte C.G. Hoegberg & Soeren Boegevig. (2021) Adverse effects from selected antidotes commonly used in poisonings. Adverse Drug Reaction Bulletin 327:1, pages 1267-1270.
Crossref
Robert Wennig. (2021) In Reply. Deutsches Ärzteblatt international.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.